Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 11,935 | 3,674 | 1,749 | 0 | 0 |
| Gross Profit | 11,935 | 3,674 | 1,749 | N/A | N/A |
| Operating Expenses | 5,549 | 9,063 | 7,880 | 5,640 | 4,538 |
| Operating Income | 6,386 | -5,389 | -6,131 | 34,210 | -4,538 |
| Other Income | -811 | 428 | 340 | 46 | 7 |
| Pre-tax Income | 5,575 | -4,961 | -5,791 | 34,256 | -4,531 |
| Income Tax | 14 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 5,561 | -4,961 | -5,791 | 33,941 | -4,531 |
| Net Income | $5,561 | $-4,961 | $-5,791 | $33,941 | $-4,531 |
| EPS Basic Total Ops | 0.26 | -0.24 | -0.28 | 1.72 | -0.22 |
| EPS Basic Continuous Ops | 0.26 | -0.24 | -0.28 | 1.72 | -0.22 |
| EPS Diluted Total Ops | 0.25 | -0.24 | -0.28 | 1.69 | -0.22 |
| EPS Diluted Continuous Ops | 0.25 | -0.24 | -0.28 | 1.69 | -0.22 |
| EBITDA(a) | $6,387 | $-5,388 | $-6,130 | $-5,639 | $-4,537 |